Sponsor:
Mayo Clinic
Code:
NCT07856394
Conditions
Metastatic Malignant Solid Neoplasm
Unresectable Malignant Solid Neoplasm
Unresectable Solid Tumor
Malignant Tumor
Metastatic Solid Tumor
Eligibility Criteria
Sex: All
Age: 15+
Healthy Volunteers: Not accepted
Interventions
Electronic Health Record Review
External Beam Radiation Therapy
Questionnaire Administration
Spatially-fractionated Radiation Therapy
Brief summary:
Conditions
Metastatic Malignant Solid Neoplasm
Unresectable Malignant Solid Neoplasm
Unresectable Solid Tumor
Malignant Tumor
Metastatic Solid Tumor
Study ID
NCT07856394
Start date
Sep 23, 2026
Status verified date
Oct, 2026
Completion date
Sep 30, 2031
Anticipated
Primary completion date
Sep 30, 2031
Anticipated
Eligibility Criteria
Sex: All
Age: 15+
Healthy Volunteers: Not accepted
Enrollment
100 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: Group I (SFRT, EBRT)
active comparator: Group II (EBRT)
Interventions
Electronic Health Record Review
External Beam Radiation Therapy
Questionnaire Administration
Spatially-fractionated Radiation Therapy
Primary outcome measure
Central contacts
Locations
Mayo Clinic in Arizona
Recruiting
Scottsdale, Arizona, United States, 85259
Contacts
Principal Investigator:
Diego A. Santos Toesca, MD
Mayo Clinic in Rochester
Recruiting
Rochester, Minnesota, United States, 55905
Contacts
Principal Investigator:
Meng X. Welliver, MD, PhD
Sponsor
Mayo Clinic
Last update posted
Oct 26, 2026
Last verified
Oct, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-17. This information was provided to ClinicalTrials.gov by Mayo Clinic on 2026-10-26. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.